Verifying Characteristics and Outcomes in Heart Failure Patients Treated with Vericiguat: VERIFY-HF

Verifying Characteristics and Outcomes in Heart Failure Patients Treated with Vericiguat: VERIFY-HF - VERIFY-HF

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054318

Enrollment

1000

Registered

2024-05-05

Start date

2024-05-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with heart failure newly prescribed vericiguat from June 2021 to September 2023

Exclusion criteria

Exclusion criteria: Less than 20 years old

Design outcomes

Primary

Measure	Time frame
Adverse events related to vericiguat	—

Countries

Japan

Contacts

Public ContactShingo Matsumoto

Toho University Faculty of Medicine Cardiology department

shingomatsumoto0606@gmail.com0337624151

Outcome results